Bicara Therapeutics Inc. · NASDAQ:BCAX
Deep Track Capital, LP reported a 6.21% stake in Bicara Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Deep Track Capital, LP reported a 6.21% stake in Bicara Therapeutics Inc., 4,062,500 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.21%
- Shares
- 4,062,500
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 6.21% | 4,062,500 |
| Deep Track Biotechnology Master Fund, Ltd. | 6.21% | 4,062,500 |
| David Kroin | 6.21% | 4,062,500 |
Source
Related
- Bicara Therapeutics Inc.
- Deep Track Capital, LP
- Bicara Therapeutics Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · Feb 12, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026